The Human Correlation Core will serve to bridge the gap between mouse models and humans. This Core will analyze a number of the newly discovered murine immune regulatory genes using primary immune cells from normal human donors. The genes will be knocked down in primary human monocytes and in CD4, CDS and B-lymphocytes using lentivirus delivered shRNA. The cells will then be challenged with relevant NIAID category A, B and C priority pathogens or with purified immune agonists, as suggested by the murine studies. The effect of each gene on the production of cytokines and eicosanoids, on signaling pathways, and on global transcriptional responses will be measured using a variety of techniques in collaboration with the Systems Biology and CyTOF cores. In collaboration with the Bioinformatics Core, the effect of these genes on immune regulatory networks will be characterized. The Human Correlation Core will monitor the growing compendium of human variants in genes of unknown function that have been associated with infectious, immune, or inflammatory disease. Mice bearing ENU induced mutations in orthologs of these genes will be bred to homozygosity, thereby providing an animal model for determining the mechanism underlying the human disease.

Public Health Relevance

Mice have traditionally been used as a model in which to study immune, infectious and inflammatory disease. However, our ultimate goal is to understand human diseases and to design therapies to combat them. This core will examine whether the disease mechanisms identified in mice are also applicable to humans.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program--Cooperative Agreements (U19)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-QV-I)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Scripps Research Institute
La Jolla
United States
Zip Code
Sun, Lei; Jiang, Zhengfan; Acosta-Rodriguez, Victoria A et al. (2017) HCFC2 is needed for IRF1- and IRF2-dependent Tlr3 transcription and for survival during viral infections. J Exp Med 214:3263-3277
Spitzer, Matthew H; Carmi, Yaron; Reticker-Flynn, Nathan E et al. (2017) Systemic Immunity Is Required for Effective Cancer Immunotherapy. Cell 168:487-502.e15
O'Gorman, W E; Kong, D S; Balboni, I M et al. (2017) Mass cytometry identifies a distinct monocyte cytokine signature shared by clinically heterogeneous pediatric SLE patients. J Autoimmun :
Miosge, Lisa A; Sontani, Yovina; Chuah, Aaron et al. (2017) Systems-guided forward genetic screen reveals a critical role of the replication stress response protein ETAA1 in T cell clonal expansion. Proc Natl Acad Sci U S A 114:E5216-E5225
Choi, Jin Huk; Wang, Kuan-Wen; Zhang, Duanwu et al. (2017) IgD class switching is initiated by microbiota and limited to mucosa-associated lymphoid tissue in mice. Proc Natl Acad Sci U S A 114:E1196-E1204
Wernig, Gerlinde; Chen, Shih-Yu; Cui, Lu et al. (2017) Unifying mechanism for different fibrotic diseases. Proc Natl Acad Sci U S A 114:4757-4762
Burnett, Deborah L; Parish, Ian A; Masle-Farquhar, Etienne et al. (2017) Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation. Immunol Cell Biol 95:775-788
Jensen, Helle; Chen, Shih-Yu; Folkersen, Lasse et al. (2017) EBI3 regulates the NK cell response to mouse cytomegalovirus infection. Proc Natl Acad Sci U S A 114:1625-1630
Zhang, Duanwu; Tomisato, Wataru; Su, Lijing et al. (2017) Skin-specific regulation of SREBP processing and lipid biosynthesis by glycerol kinase 5. Proc Natl Acad Sci U S A 114:E5197-E5206
Mukherjee, Sayak; Jensen, Helle; Stewart, William et al. (2017) In silico modeling identifies CD45 as a regulator of IL-2 synergy in the NKG2D-mediated activation of immature human NK cells. Sci Signal 10:

Showing the most recent 10 out of 106 publications